美国NDC复合药物数据库文件

药品名称：商品名称：药品NDC：报告期内： -格式:2020-5-3
NDC包装id：市场分类：活性成分：持证企业：

美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)

药品名称(分析)

商品名

药品NDC

专利人(分析)

报告期内

活性成分

市场分类

规格(分析)

NDC包装id

fentanyl citrate, bupivacaine hydrochloride

HUMAN COMPOUNDED DRUG

73013-1028

OurPharma LLC

2023-2

BUPIVACAINE HYDROCHLORIDE; FENTANYL CITRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1.25 mg/1 mL; 2 ug/1 mL

73013-1028-1

Ketamine HCl

HUMAN COMPOUNDED DRUG

73013-2000

OurPharma LLC

2023-2

KETAMINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

50 mg/1 mL

73013-2000-2

fentanyl citrate

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 ug/1 mL

73013-1013-1

Succinylcholine Cl 100 mg per 5 mL Syringe (20 mg/mL)

HUMAN COMPOUNDED DRUG

71170-020

Apollo Care, LLC

2024-2

SUCCINYLCHOLINE CHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

20 mg/1 mL

71170-020-05

Vancomycin 2g added to 500mL of 0.9% Sodium Chloride

HUMAN COMPOUNDED DRUG

71170-204

Apollo Care, LLC

2024-2

VANCOMYCIN HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

4 mg/1 mL

71170-204-50

Vancomycin 2.5g added to 500mL of 0.9% Sodium Chloride

HUMAN COMPOUNDED DRUG

71170-224

Apollo Care, LLC

2024-2

VANCOMYCIN HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

5 mg/1 mL

71170-224-50

Fentanyl 500mcg 2mcg/mL and Ropivacaine HCl 250mg added to 250mL 0.9% Sodium Chloride Injection (For Epidural Use Only)

HUMAN COMPOUNDED DRUG

71170-950

Apollo Care, LLC

2024-2

ROPIVACAINE HYDROCHLORIDE; FENTANYL CITRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL; 2 ug/1 mL

71170-950-25

Phenylephrine HCl 1 mg per 10 mL Syringe (100 mcg/mL)

HUMAN COMPOUNDED DRUG

71170-010

Apollo Care, LLC

2024-2

PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

100 ug/1 mL

71170-010-10

Norepinephrine Bitartrate 8mg added to 250mL of 0.9% Sodium Chloride

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.032 mg/1 mL

71170-550-25

TESTOSTERONE 50MG

HUMAN COMPOUNDED DRUG

73693-401

FARMAKEIO OUTSOURCING LLC

2024-2

TESTOSTERONE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

50 mg

73693-401-01

TESTOSTERONE 50 MG

HUMAN COMPOUNDED DRUG

73693-387

FARMAKEIO OUTSOURCING LLC

2024-2

TESTOSTERONE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

50 mg

73693-387-01

TESTOSTERONE 37.5 MG

HUMAN COMPOUNDED DRUG

73693-388

FARMAKEIO OUTSOURCING LLC

2024-2

TESTOSTERONE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

37.5 mg

73693-388-01

ESTRADIOL 25MG

HUMAN COMPOUNDED DRUG

73693-378

FARMAKEIO OUTSOURCING LLC

2024-2

ESTRADIOL

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

25 mg

73693-378-01

TESTOSTERONE 87.5 MG

HUMAN COMPOUNDED DRUG

73693-386

FARMAKEIO OUTSOURCING LLC

2024-2

TESTOSTERONE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

87.5 mg

73693-386-01

TESTOSTERONE 62.5 MG

HUMAN COMPOUNDED DRUG

73693-383

FARMAKEIO OUTSOURCING LLC

2024-2

TESTOSTERONE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

62.5 mg

73693-383-01

TESTOSTERONE 25 MG

HUMAN COMPOUNDED DRUG

73693-389

FARMAKEIO OUTSOURCING LLC

2024-2

TESTOSTERONE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

25 mg

73693-389-01

TESTOSTERONE, TRIAMCINOLONE 100MG, 20MCG

HUMAN COMPOUNDED DRUG

73693-367

FARMAKEIO OUTSOURCING LLC

2024-2

TESTOSTERONE; TRIAMCINOLONE ACETONIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

100 mg; 20 ug

73693-367-01

Modified St. Thomas High K (106 mEq) High Sodium Bicarbonate 1000 mL Bag

HUMAN COMPOUNDED DRUG

72196-0204

Central Admixture Pharmacy Services, Inc.

2024-2

POTASSIUM CHLORIDE; SODIUM BICARBONATE; CALCIUM CHLORIDE; SODIUM CHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

106 meq/1000 mL; 3.864 g/1000 mL; 2.176 meq/1000 mL; 100 meq/1000 mL; 29.232 meq/1000 mL

72196-0204-1

Trophamine 4.5%/Dextrose 10% With Heparin 125 units 250ml in 250ml bag

HUMAN COMPOUNDED DRUG

72196-0432

Central Admixture Pharmacy Services, Inc.

2024-2

HEPARIN SODIUM; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; GLUTAMIC ACID; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

125 U/250 mL; 1.35 g/250 mL; .4275 g/250 mL; .0495 g/250 mL; .27 g/250 mL; .4725 g/250 mL; .027 g/250 mL; .54 g/250 mL; 1.35 g/250 mL; .028125 g/250 mL; 25 g/250 mL; 1.575 g/250 mL; .3825 g/250 mL; .5625 g/250 mL; .765 g/250 mL; .36 g/250 mL; .9225 g/250 mL; .6075 g/250 mL; .405 g/250 mL; .54 g/250 mL; .225 g/250 mL; .8775 g/250 mL

72196-0432-1

Trophamine 2% / Dextrose 10% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag

HUMAN COMPOUNDED DRUG

72196-0416

Central Admixture Pharmacy Services, Inc.

2024-2

LYSINE ACETATE; SERINE; GLUTAMIC ACID; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; CALCIUM GLUCONATE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; HEPARIN SODIUM

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.6 g/250 mL; .19 g/250 mL; .25 g/250 mL; .022 g/250 mL; .12 g/250 mL; .21 g/250 mL; .012 g/250 mL; .24 g/250 mL; .6 g/250 mL; .0125 g/250 mL; 25 g/250 mL; 3.75 meq/250 mL; .7 g/250 mL; .17 g/250 mL; .34 g/250 mL; .16 g/250 mL; 41 g/250 mL; .27 g/250 mL; .18 g/250 mL; .24 g/250 mL; .1 g/250 mL; .39 g/250 mL; 125 U/250 mL

72196-0416-1

网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:330683240604819103159
　医药代理商群１：

医药代理商群２：

医药代理商群３：